Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

This is in reference to the Scheme of Amalgamation of Gufic Lifesciences Private Limited with Gufic Biosciences Limited and their respective shareholders and creditors, which was filed with the Stock Exchanges for their approval/no objection in terms of Regulation 37 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We are pleased to inform that we have received no adverse observation from BSE Limited and National Stock Exchange of India Limited vide their letters dated April 15, 2020 on the draft Scheme of Amalgamation. The said letters are enclosed herewith for your reference. The Company would now approach Hon'ble National Company Law Tribunal for further process. Any developments in the above shall be duly intimated.
16-04-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Clarification

With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Gufic Biosciences Ltd has submitted to BSE a copy of Clarification is enclosed.
13-04-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Clarification sought from Gufic Biosciences Ltd

The Exchange has sought clarification from Gufic Biosciences Ltd on April 13, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
13-04-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window

Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company's Code of Conduct framed under the said provisions , the Trading Window for dealing in securities of the Company shall remain closed for all the Insiders (including Directors and Connected/ Designated Persons and their immediate relatives) from the close of business hours of Tuesday, March 31, 2020 till 48 hours after the declaration of Audited Financial Results of the Company for the quarter and year ended March 31, 2020. The date of meeting of the Board of Directors to consider and approve the Audited Financial Result of the Company for the said period shall be informed in due course.
30-03-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Outcome Of The Board Meeting

Please find attached herewith scanned copy of outcome of the Board Meeting held today.
13-02-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Results- Financial Results For Quarter And Nine Months Ended December 31, 2019

Enclosed herewith is the Un-audited Financial Results of the Company for the quarter and Nine months ended December 31, 2019 along with the Limited Review Report received from the Statutory Auditor of the Company on the said Un-Audited Financial Results.
13-02-2020
Bigul

Gufic Biosciences Ltd - 509079 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2019.

GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2020 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2019.
06-02-2020
Bigul

Gufic Biosciences Ltd - 509079 - Shareholding for the Period Ended December 31, 2019

Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
18-01-2020
Bigul

Gufic Biosciences Ltd - 509079 - Statement Of Investor Complaints For The Quarter Ended December 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ami ShahDesignation :- Company Secretary and Compliance Officer
13-01-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window

Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company's Code of Conduct framed under the said provisions, the Trading Window for dealing in securities of the Company shall remain closed for all the Insiders (including Directors and Connected/ Designated Persons and their immediate relatives) from Wednesday, January 01, 2020 till 48 hours after the declaration of Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2019. Kindly take the same on record.
01-01-2020
Next Page
Close

Let's Open Free Demat Account